Hypertension Management in Terms of Routine Agents
Trial statusNot yet recruiting
Trial phaseNot listed
Trial typeObservational
Biological sexAll
Age18+
SponsorSaglik Bilimleri Universitesi
About this trial
known hypertensive patients admitted to emergency department with increased blood pressure will be evaluated in terms of antihypertensive agents given at hospital, degree of blood pressure decrease, hospital stay and laboratory and imaging tests ordered. The impact of routine oral antihypertensive agents used by the patients on these parameter will be assessed.
Eligibility criteria
This trial does not accept healthy volunteersQualifiers
Patients aged 18 and older.
Blood pressure measured at ≥140/80.
Diagnosis of essential hypertension.
Disqualifiers
Pregnant patients.
Individuals without a prior diagnosis of hypertension.
Patients with end-organ damage (hypertensive emergency).
Patients whose routine antihypertensive agents are unavailable.
Trial population
patients with known hypertension admitted to emergency department with elevated blood pressure
Trial design
Design model
Cohort
Time perspective
Prospective
Treatments tested in this trial
Not listed
Trial groups
350 Participants
are grouped into 6 trial groups6
Trial groupsSee each trial group below.
Group A: diuretics
Group B: Beta Blockers
Group C: Calcium Channel Blockers
Group D: ACE (angiotensin converting enzyme) Inhibitors
Group E: ARB( angiotensin receptor blockers)
Group F: combination
Trial outcomes
Primary outcomes
1
routine use of oral antihypertensive agents and its effects on emergency service care
emergency service blood pressure target achievement duration changes depending on routine oral antihypertensive agent prescribed
Time frame
from enrollment to the end of follow up duration of 7 daysSponsors and contacts
Click on the lead sponsor to view all of their trials.
Saglik Bilimleri Universitesi
Lead sponsor
Etimesgut Military Hospital
Collaborator
Source ClinicalTrials.gov
This trial is not recruiting at the moment. You can still explore other options: